Medicine and Dentistry
Patient
100%
Neoplasm
47%
Metastatic Carcinoma
38%
Therapeutic Procedure
32%
Inpatient
31%
Malignant Neoplasm
28%
Gene
27%
Overall Survival
26%
Radiation Therapy
25%
Cancer Cell
16%
Liver Metastasis
16%
Systemic Therapy
16%
Hazard Ratio
16%
Next Generation Sequencing
15%
Colorectal Cancer
14%
Age
14%
Surgery
14%
Progression Free Survival
13%
Chemotherapy
13%
Rectum Cancer
12%
Hepatocellular Carcinoma
12%
Diagnosis
10%
Analysis
10%
Combination Therapy
10%
Organ
10%
Survival
10%
Toxicity
10%
Diseases
9%
Elderly Patient
9%
Periodontitis
9%
Cancer Associated Fibroblast
9%
Fusobacterium nucleatum
9%
Liver
9%
Folinic Acid
8%
Lung
8%
Microenvironment
8%
Radiosensitivity
8%
Chemoradiotherapy
8%
Tumor Progression
8%
Ablation Therapy
8%
Cells
8%
Lesion
8%
Atezolizumab
8%
Bevacizumab
8%
Breast Cancer
7%
Oxaliplatin
7%
Chemotherapy
7%
Colorectal Carcinoma
7%
Follow up
6%
Exosome
6%
Biochemistry, Genetics and Molecular Biology
Nested Gene
31%
Mutation
25%
Cancer Cell
16%
KRAS
12%
Protein
10%
Age
9%
DNA
9%
Fibroblast
9%
Suspension
9%
Radiosensitivity
8%
Sample
7%
Overall Survival
7%
Growth
7%
Overall Survival
6%
Liquid
6%
RNA
6%
Cohort Study
6%
Cyclodextrin
6%
Flow
6%
Field Flow Fractionation
6%
Probe
6%
Data Base
5%
Wild Type
5%
Survival
5%
Clusterin
5%
Guide RNA
5%
Signal Transduction
5%
Smoking
5%
Reprogramming
5%
Association
5%
Pharmacology, Toxicology and Pharmaceutical Science
Metastasis
16%
Overall Survival
15%
Toxicity
12%
Neoplasm
11%
Progression Free Survival
10%
Periodontitis
9%
Malignant Neoplasm
8%
Chemotherapy
8%
Liver Metastasis
6%
Diseases
6%
Cisplatin
6%
Nivolumab
5%
Metastatic Colorectal Cancer
5%
Survival
5%
Stomach Cancer
5%